跳至主要内容
临床试验/KCT0008120
KCT0008120尚未招募未知

Effects of age on Optimal effect-site concentration of remimazolam for efficacy of general anesthetic duction in female patients

Ajou University Hospital0 个研究点目标入组 90 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
20(Year) 至 75(Year)(—)
性别
Female

入选标准

  • Female patients (20-39 years old group, 40-59 years old group, 60-75 years old group ) who correspond to ASA 1 and 2, weight <100 kg, and are scheduled to general anesthesia.

排除标准

  • Patients with BMI > 30 kg/m2 or < 20 kg/m2, patients with contraindications such as allergies to this study drug, patients with hearing impairment, etc., who are unable to respond to the researcher's verbal command, or patients with liver disease (bilirubin =3.0 mg/dl, or aspartate amino transferase/alanine aminotransferase = 2.5 x upper limits of normal), renal disease (creatine = 2 mg/dl), chronic obstructive pulmonary disease, uncontrolled hypertension ( e.g. Patients with systolic BP =160 mmHg), diabetes (HbA1c = 9%), moderate to severe coronary artery disease, glaucoma, heart failure, or taking other medications that may affect the effectiveness of benzodiazepines despite taking blood pressure medications If present, a history of smoking (within the last 6 months). If the IV line is placed on the back of the hand.

研究者

发起方
Ajou University Hospital

相似试验